Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
wt decrease » _ decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
-
39241
TS1 parameters.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39242
TS3 parameters.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39243
-
39244
Image_1_Oat polar lipids and sunflower lecithin similarly improve cardiometabolic risk markers and appetite controlling hormone responses after breakfast and a subsequent lunch. A...
Published 2024“…The meals were served as breakfast followed by a standardised lunch (white wheat bread and meat balls) after 3.5 h. …”
-
39245
HBF design results minimize <i>P</i><sub><i>LOSS</i></sub> in TS2.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39246
HBF design results to minimize <i>P<sub>LOSS</sub></i> in TS1.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39247
HBF design parameters for TS3.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39248
HBF design parameters for TS1.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39249
HBF design parameters for TS2.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39250
HBF design results minimize P<sub>LOSS</sub> in TS3.
Published 2025“…In TS3, the SFS-optimized HBF decreases <i>THD</i><sub><i>V</i></sub> by 45.71%, <i>TDD</i><sub><i>I</i></sub> by 99.96%, and <i>P</i><sub><i>LOSS</i></sub> by 33.26% compared to the uncompensated case. …”
-
39251
-
39252
DataSheet_1_A new technique of quantifying protoporphyrin IX in microbial cells in seawater.docx
Published 2022“…The results showed that PPIX existed widely and ranged from 20 – 170 ng/L in cells in the water samples. In the whole estuary, cellular PPIX generally decreased linearly with increasing salinity. …”
-
39253
-
39254
Table_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX
Published 2019“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
-
39255
Table_2_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX
Published 2019“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
-
39256
Image_1_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.pdf
Published 2019“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
-
39257
A Dominated Coupling From The Past algorithm for the stochastic simulation of networks of biochemical reactions-4
Published 2011“…In the simplified cartoon, each circle represents a gene repressing the subsequent gene in a cycle. …”
-
39258
Table_4_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX
Published 2019“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”
-
39259
A: <i>In vitro</i> immunomodulatory effect of HD-MSCs and ALL-MSCs on HD-PBMCs.
Published 2013“…</i> IL6, IL10 and TGFb) was detected in the presence of both HD-MSCs and ALL-MSCs, as compared with PHA-stimulated PBMC cultures. A decrease in pro-inflammatory cytokines and growth factors (GM-CSF, IL2 and IFNg) was revealed in supernatants collected from the same co-cultures. …”
-
39260
Table_3_Cerebrovascular Disease and Perioperative Neurologic Vulnerability: A Prospective Cohort Study.DOCX
Published 2019“…</p><p>Results: Cerebral desaturation events (an oximetry decrease ≥20% from baseline or <50% absolute value for ≥3 min) occurred in 7/24 (29%) cerebrovascular disease patients and 2/24 (8.3%) controls (relative risk 3.5, 95% CI 0.81–15.2; P = 0.094). …”